Technion Israel Institute of Technology
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Technion Israel Institute of Technology
A review of biopharma start-up dealmaking and financing activity from April through June 2017, based on data from Strategic Transactions, showed that fundraising activity more than doubled compared with the first quarter.
June venture capital financings for emerging companies totaled more than $688.8m, ranging from an undisclosed round for Avitide to a $120m Series B for Rubius Therapeutics.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2017.
Israeli start-up Hemonitor Medical is hoping to make waves with a new hemodynamic monitor that uses an ultrasound patch technology to continuously monitor blood flow in ICU patients or patients in surgery. The company is the first start-up to be taken in by MindUP, Israel's first digital health incubator and a joint partnership between Medtronic, IBM, Pitango Venture Capital, Rambam Hospital and the Impact First investment fund.
- Academic and Research Institutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.